When semaglutide may be preferred Established cardiovascular disease SELECT trial provides cardiovascular mortality data that tirzepatides SURMOUNT-MMO cannot yet match When an oral option is important Rybelsus (oral semaglutide) has no tirzepatide equivalent Prior tolerance established for patients already on Ozempic who are transitioning to a weight management indication Insurance coverage specifically for Wegovy when Zepbound is not covered When tirzepatide may be preferred Maximum weight loss is the primary goal tirzepatide consistently produces larger average weight loss Type 2 diabetes with significant HbA1c reduction needed tirzepatide outperforms semaglutide on glycemic endpoints Prior GI intolerance on semaglutide some patients tolerate tirzepatide better, though this is individual Cost Zepbounds list price is modestly lower than Wegovy, and Eli Lillys self-pay vial program may offer better access for uninsured patients When the choice doesnt matter much For patients who respond well to either drug at therapeutic doses, the practical difference in outcome may be smaller than the trial averages suggest

Semaglutide works for weight loss by mimicking the action of incretin, a natural gut hormone called GLP-1, and targeting GLP-1 receptors in the brain that control appetite and slow down how quickly the stomach empties, making you feel fuller for longer
Studies suggest that dysbiosis may affect the metabolism of dietary components, increase inflammation, and alter gut hormone signaling, leading to the development of obesity
All treatments require evaluation and guidance from a licensed healthcare provider
The chemical constituents of this plant are luteolin, isoorientin, and chlorogenic acid